JP2004502674A - エイズを治療するためのピロール誘導体 - Google Patents
エイズを治療するためのピロール誘導体 Download PDFInfo
- Publication number
- JP2004502674A JP2004502674A JP2002507781A JP2002507781A JP2004502674A JP 2004502674 A JP2004502674 A JP 2004502674A JP 2002507781 A JP2002507781 A JP 2002507781A JP 2002507781 A JP2002507781 A JP 2002507781A JP 2004502674 A JP2004502674 A JP 2004502674A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- isopropyl
- pyridyl
- pyrrole
- dichlorophenylthio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003233 pyrroles Chemical class 0.000 title abstract description 21
- 208000030507 AIDS Diseases 0.000 title description 4
- -1 methyl Oxycarbonyl Chemical group 0.000 claims abstract description 516
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 174
- 150000001875 compounds Chemical class 0.000 claims abstract description 135
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 96
- 239000001257 hydrogen Substances 0.000 claims abstract description 66
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 66
- 125000003118 aryl group Chemical group 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 50
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 44
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 26
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 25
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 24
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 23
- 150000002148 esters Chemical class 0.000 claims abstract description 22
- 241000725303 Human immunodeficiency virus Species 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 14
- 230000001404 mediated effect Effects 0.000 claims abstract description 12
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 106
- 125000001424 substituent group Chemical group 0.000 claims description 74
- 239000000203 mixture Substances 0.000 claims description 57
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 49
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 39
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 33
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 28
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 27
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 22
- 229910052736 halogen Inorganic materials 0.000 claims description 21
- 150000002367 halogens Chemical class 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 17
- 201000010099 disease Diseases 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 11
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 10
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 9
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- ILFIRBGRMCGNOO-UHFFFAOYSA-N 1,1-bis($l^{1}-oxidanyl)ethene Chemical group [O]C([O])=C ILFIRBGRMCGNOO-UHFFFAOYSA-N 0.000 claims description 8
- DGYIJVNZSDYBOE-UHFFFAOYSA-N [CH2]C1=CC=NC=C1 Chemical group [CH2]C1=CC=NC=C1 DGYIJVNZSDYBOE-UHFFFAOYSA-N 0.000 claims description 8
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 7
- 150000001540 azides Chemical class 0.000 claims description 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 6
- 239000012336 iodinating agent Substances 0.000 claims description 6
- GNEDCDOSYXWZDO-UHFFFAOYSA-N 2-iodo-1h-pyrrole Chemical class IC1=CC=CN1 GNEDCDOSYXWZDO-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- VBYXIATXFWEYOE-UHFFFAOYSA-N 1-[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]propan-2-ol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CC(O)C)=CN1CC1=CC=NC=C1 VBYXIATXFWEYOE-UHFFFAOYSA-N 0.000 claims description 4
- XKFSJQJRYDRRAS-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carbaldehyde Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C=O)=C(C)N1CC1=CC=NC=C1 XKFSJQJRYDRRAS-UHFFFAOYSA-N 0.000 claims description 4
- RRDWYNMKASTPOP-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanamine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CN)=C(C)N1CC1=CC=NC=C1 RRDWYNMKASTPOP-UHFFFAOYSA-N 0.000 claims description 4
- GRNQWGLQZKJIIO-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 GRNQWGLQZKJIIO-UHFFFAOYSA-N 0.000 claims description 4
- FNYYHEZFHAUXPH-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C=C(CO)N1CC1=CC=NC=C1 FNYYHEZFHAUXPH-UHFFFAOYSA-N 0.000 claims description 4
- TZUFOVKURPPYOG-UHFFFAOYSA-N 1-[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]ethanone Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(C)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 TZUFOVKURPPYOG-UHFFFAOYSA-N 0.000 claims description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- GVGGAWRZMNKCRT-UHFFFAOYSA-N 4-[[2-(3-bromo-5-chlorophenyl)sulfanyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Br)=CC=1SC1=C(C(C)C)C=C(C)N1CC1=CC=NC=C1 GVGGAWRZMNKCRT-UHFFFAOYSA-N 0.000 claims description 3
- BMXZFHZKHQJVCW-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxylic acid Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(O)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 BMXZFHZKHQJVCW-UHFFFAOYSA-N 0.000 claims description 3
- PBHQJBDDHVASAJ-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-3-(hydroxymethyl)-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-2-carbaldehyde Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C=O)N1CC1=CC=NC=C1 PBHQJBDDHVASAJ-UHFFFAOYSA-N 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- MGOGKPMIZGEGOZ-REOHCLBHSA-N (2s)-2-amino-3-hydroxypropanamide Chemical compound OC[C@H](N)C(N)=O MGOGKPMIZGEGOZ-REOHCLBHSA-N 0.000 claims description 2
- UYJLCHZWBYASFB-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-4-ethenyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C=C)=C(C)N1CC1=CC=NC=C1 UYJLCHZWBYASFB-UHFFFAOYSA-N 0.000 claims description 2
- OIOFYKBHMYIXQQ-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C=C(C)N1CC1=CC=NC=C1 OIOFYKBHMYIXQQ-UHFFFAOYSA-N 0.000 claims description 2
- HJDFVDXLTFBFIE-UHFFFAOYSA-N 4-[[4-(azidomethyl)-2-(3,5-dichlorophenyl)sulfanyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CN=[N+]=[N-])=C(C)N1CC1=CC=NC=C1 HJDFVDXLTFBFIE-UHFFFAOYSA-N 0.000 claims description 2
- FSJSSNUNXMMQNT-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-phenyl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C=2C=CC=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 FSJSSNUNXMMQNT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- NHRYXUAOTWGULV-UHFFFAOYSA-N ethyl 2-[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]-2-oxoacetate Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C(=O)C(=O)OCC)=C(C)N1CC1=CC=NC=C1 NHRYXUAOTWGULV-UHFFFAOYSA-N 0.000 claims description 2
- CGHZXFOQSJGMKE-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-4-(methoxymethyl)-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(COC)=C(C)N1CC1=CC=NC=C1 CGHZXFOQSJGMKE-UHFFFAOYSA-N 0.000 claims 3
- ZKGHJMSPQNUHSU-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-3-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=CN=C1 ZKGHJMSPQNUHSU-UHFFFAOYSA-N 0.000 claims 3
- RVXJAYPWEXAJCW-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-4,5-dimethyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C)=C(C)N1CC1=CC=NC=C1 RVXJAYPWEXAJCW-UHFFFAOYSA-N 0.000 claims 2
- DAWSCXAALVCTQY-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 DAWSCXAALVCTQY-UHFFFAOYSA-N 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- WEBRUTUJHUWZPN-UHFFFAOYSA-N [1-(cyclohexylmethyl)-5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1CCCCC1 WEBRUTUJHUWZPN-UHFFFAOYSA-N 0.000 claims 2
- RWYKLZFFVYBQAD-UHFFFAOYSA-N [1-benzyl-5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=CC=C1 RWYKLZFFVYBQAD-UHFFFAOYSA-N 0.000 claims 2
- NNVYGLJOFBQUBO-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1,5-bis(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 NNVYGLJOFBQUBO-UHFFFAOYSA-N 0.000 claims 2
- BKTSAGBCUJXLTR-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-5-propan-2-ylsulfanyl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound CC(C)SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 BKTSAGBCUJXLTR-UHFFFAOYSA-N 0.000 claims 2
- QQOHZSYPNKNGGD-UHFFFAOYSA-N [2-methyl-5-(3-nitrophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC([N+]([O-])=O)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 QQOHZSYPNKNGGD-UHFFFAOYSA-N 0.000 claims 2
- KKGUOCPIQVMCOE-UHFFFAOYSA-N [2-methyl-5-methylsulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound CSC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 KKGUOCPIQVMCOE-UHFFFAOYSA-N 0.000 claims 2
- BIPMUHHCDPZFDD-UHFFFAOYSA-N [2-methyl-5-phenylsulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 BIPMUHHCDPZFDD-UHFFFAOYSA-N 0.000 claims 2
- NFCCDFQEHMMNDJ-UHFFFAOYSA-N [4-(3,4-dichlorophenyl)-5-(3,5-dichlorophenyl)sulfanyl-2-methyl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(C)=C(CO)C(C=2C=C(Cl)C(Cl)=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 NFCCDFQEHMMNDJ-UHFFFAOYSA-N 0.000 claims 2
- DXNOEFFEXRUKQV-UHFFFAOYSA-N [4-(4-chlorophenyl)-5-(3,5-dichlorophenyl)sulfanyl-2-methyl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(C)=C(CO)C(C=2C=CC(Cl)=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 DXNOEFFEXRUKQV-UHFFFAOYSA-N 0.000 claims 2
- NBWTVIWCGQNXPX-UHFFFAOYSA-N [5-(3,5-dichlorophenoxy)-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1OC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 NBWTVIWCGQNXPX-UHFFFAOYSA-N 0.000 claims 2
- YKBHCELMYZVYRK-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-1,2-dimethyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound OCC1=C(C)N(C)C(SC=2C=C(Cl)C=C(Cl)C=2)=C1C(C)C YKBHCELMYZVYRK-UHFFFAOYSA-N 0.000 claims 2
- NJVGRAQSDIYKSQ-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-1-ethyl-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound CCN1C(C)=C(CO)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 NJVGRAQSDIYKSQ-UHFFFAOYSA-N 0.000 claims 2
- JTVDNMOWWJSBHU-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-(hydroxymethyl)-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(CO)N1CC1=CC=NC=C1 JTVDNMOWWJSBHU-UHFFFAOYSA-N 0.000 claims 2
- NTJNOHWOFUHLMK-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-ethyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(CC)=C(CO)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 NTJNOHWOFUHLMK-UHFFFAOYSA-N 0.000 claims 2
- SGKJTZQKGHLJGF-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-(4-methylphenyl)-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(C)=C(CO)C(C=2C=CC(C)=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 SGKJTZQKGHLJGF-UHFFFAOYSA-N 0.000 claims 2
- HGLXOJRVWUUAKR-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-phenyl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(C)=C(CO)C(C=2C=CC=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 HGLXOJRVWUUAKR-UHFFFAOYSA-N 0.000 claims 2
- LXOCSTAMCATDJJ-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-2-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=CC=N1 LXOCSTAMCATDJJ-UHFFFAOYSA-N 0.000 claims 2
- YJCFENCRTMKYEX-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-3-methyl-1-propan-2-yl-4-(pyridin-4-ylmethyl)pyrrol-2-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC=1N(C(C)C)C(CO)=C(C)C=1CC1=CC=NC=C1 YJCFENCRTMKYEX-UHFFFAOYSA-N 0.000 claims 2
- AMHJEIVVLLXFTI-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-3-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C)=C(CO)N1CC1=CC=NC=C1 AMHJEIVVLLXFTI-UHFFFAOYSA-N 0.000 claims 2
- YCZNSHYMCQVRII-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-4-(4-methoxyphenyl)-2-methyl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C1=CC(OC)=CC=C1C1=C(SC=2C=C(Cl)C=C(Cl)C=2)N(CC=2C=CN=CC=2)C(C)=C1CO YCZNSHYMCQVRII-UHFFFAOYSA-N 0.000 claims 2
- IQXFKQNAMUFNKC-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=CN1CC1=CC=NC=C1 IQXFKQNAMUFNKC-UHFFFAOYSA-N 0.000 claims 2
- SMBIBSZOLMAENG-UHFFFAOYSA-N [5-(3,5-dimethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(C)=CC(C)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 SMBIBSZOLMAENG-UHFFFAOYSA-N 0.000 claims 2
- SUMWWNMGUWJJOZ-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 SUMWWNMGUWJJOZ-UHFFFAOYSA-N 0.000 claims 2
- DPFRZEZAQSAVJW-UHFFFAOYSA-N [5-[(3,5-dichlorophenyl)methylamino]-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1CNC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 DPFRZEZAQSAVJW-UHFFFAOYSA-N 0.000 claims 2
- OJLVSALJZYYANA-UHFFFAOYSA-N [5-benzyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC=CC=1CC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 OJLVSALJZYYANA-UHFFFAOYSA-N 0.000 claims 2
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims 2
- VSYUMEHTRWAFIY-UHFFFAOYSA-N 1-[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]ethane-1,2-diol Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(O)CO)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 VSYUMEHTRWAFIY-UHFFFAOYSA-N 0.000 claims 1
- UHETYCVGVZTFIO-UHFFFAOYSA-N 1-[5-(3,5-dichlorophenyl)sulfanyl-3-(hydroxymethyl)-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]propan-2-ol Chemical compound C=1C=NC=CC=1CN1C(CC(O)C)=C(CO)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 UHETYCVGVZTFIO-UHFFFAOYSA-N 0.000 claims 1
- ZKZATDCRNSKMMS-UHFFFAOYSA-N 1-[5-(3-chlorophenyl)sulfanyl-2-(hydroxymethyl)-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]propan-2-ol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CC(O)C)=C(CO)N1CC1=CC=NC=C1 ZKZATDCRNSKMMS-UHFFFAOYSA-N 0.000 claims 1
- ASFDKSDGSHWMLF-UHFFFAOYSA-N 3-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]-1,1-dimethylurea Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CNC(=O)N(C)C)=C(C)N1CC1=CC=NC=C1 ASFDKSDGSHWMLF-UHFFFAOYSA-N 0.000 claims 1
- OMEHUFOPZVQGGP-UHFFFAOYSA-N 3-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]-1-methyl-1-phenylurea Chemical compound CC=1N(CC=2C=CN=CC=2)C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C=1CNC(=O)N(C)C1=CC=CC=C1 OMEHUFOPZVQGGP-UHFFFAOYSA-N 0.000 claims 1
- WBRZNNZMKUURDZ-UHFFFAOYSA-N 3-chloro-5-[5-methyl-3-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]sulfanylbenzonitrile Chemical compound C=1C(Cl)=CC(C#N)=CC=1SC1=C(C(C)C)C=C(C)N1CC1=CC=NC=C1 WBRZNNZMKUURDZ-UHFFFAOYSA-N 0.000 claims 1
- GJORGPKRFKERIK-UHFFFAOYSA-N 4-[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]but-3-en-2-one Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C=C(C=CC(C)=O)N1CC1=CC=NC=C1 GJORGPKRFKERIK-UHFFFAOYSA-N 0.000 claims 1
- HQGXXMRKOAEBLZ-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-5-(ethoxymethyl)-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C=NC=CC=1CN1C(COCC)=CC(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 HQGXXMRKOAEBLZ-UHFFFAOYSA-N 0.000 claims 1
- KXIDILNNRXRASL-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-5-(methoxymethyl)-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C=NC=CC=1CN1C(COC)=CC(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 KXIDILNNRXRASL-UHFFFAOYSA-N 0.000 claims 1
- KDDFUQHKASXOGQ-UHFFFAOYSA-N 4-[[2-(3,5-dichlorophenyl)sulfanyl-5-methyl-3-phenylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C=NC=CC=1CN1C(C)=CC(C=2C=CC=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 KDDFUQHKASXOGQ-UHFFFAOYSA-N 0.000 claims 1
- JJZJMWLIUDLISF-UHFFFAOYSA-N 4-[[2-(3-chloro-5-propylphenyl)sulfanyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound CCCC1=CC(Cl)=CC(SC=2N(C(C)=CC=2C(C)C)CC=2C=CN=CC=2)=C1 JJZJMWLIUDLISF-UHFFFAOYSA-N 0.000 claims 1
- PSWWDBKSAXQBOE-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)sulfanyl-4-(methoxymethyl)-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(COC)=C(C)N1CC1=CC=NC=C1 PSWWDBKSAXQBOE-UHFFFAOYSA-N 0.000 claims 1
- WANGVNBSLXKJEM-UHFFFAOYSA-N 4-cyclopropyl-5-(3,5-dichlorophenyl)sulfanyl-2-methyl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC=1N(CC=2C=CN=CC=2)C(C)=C(C(N)=O)C=1C1CC1 WANGVNBSLXKJEM-UHFFFAOYSA-N 0.000 claims 1
- GYLKEBXAWHWEAD-UHFFFAOYSA-N 5-(3,5-dibromophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC(Br)=CC(Br)=C1 GYLKEBXAWHWEAD-UHFFFAOYSA-N 0.000 claims 1
- NJCQGPHKDQXOQE-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-phenyl-1-(pyridin-4-ylmethyl)-n-[(2,4,6-trimethoxyphenyl)methyl]pyrrole-3-carboxamide Chemical compound COC1=CC(OC)=CC(OC)=C1CNC(=O)C(C(=C1SC=2C=C(Cl)C=C(Cl)C=2)C=2C=CC=CC=2)=C(C)N1CC1=CC=NC=C1 NJCQGPHKDQXOQE-UHFFFAOYSA-N 0.000 claims 1
- TVQMJMFEEIQZCI-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-phenyl-1-(pyridin-4-ylmethyl)pyrrole-3-carbonitrile Chemical compound C=1C=NC=CC=1CN1C(C)=C(C#N)C(C=2C=CC=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 TVQMJMFEEIQZCI-UHFFFAOYSA-N 0.000 claims 1
- KJCDLYUNVHWLTI-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-phenyl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=NC=CC=1CN1C(C)=C(C(O)=O)C(C=2C=CC=CC=2)=C1SC1=CC(Cl)=CC(Cl)=C1 KJCDLYUNVHWLTI-UHFFFAOYSA-N 0.000 claims 1
- TWLYXEAXIBVZOV-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-2,3-dicarbaldehyde Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C=O)=C(C=O)N1CC1=CC=NC=C1 TWLYXEAXIBVZOV-UHFFFAOYSA-N 0.000 claims 1
- XOMQXYANSPHQPA-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-2-carbaldehyde Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C=C(C=O)N1CC1=CC=NC=C1 XOMQXYANSPHQPA-UHFFFAOYSA-N 0.000 claims 1
- SSQPPOGYXDBFLR-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-n,2-dimethyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C(=O)NC)=C(C)N1CC1=CC=NC=C1 SSQPPOGYXDBFLR-UHFFFAOYSA-N 0.000 claims 1
- IAFRKQXVDKCBQJ-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-n,n,2-trimethyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(=O)N(C)C)C(C(C)C)=C1SC1=CC(Cl)=CC(Cl)=C1 IAFRKQXVDKCBQJ-UHFFFAOYSA-N 0.000 claims 1
- RHCVTKWMOUSDCH-UHFFFAOYSA-N 5-(3,5-dimethoxyphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound COC1=CC(OC)=CC(SC=2N(C(C)=C(C(N)=O)C=2C(C)C)CC=2C=CN=CC=2)=C1 RHCVTKWMOUSDCH-UHFFFAOYSA-N 0.000 claims 1
- URIUWGUGLISJPE-UHFFFAOYSA-N 5-(3-bromo-5-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(Br)=C1 URIUWGUGLISJPE-UHFFFAOYSA-N 0.000 claims 1
- OBISXTAFFOXIBB-UHFFFAOYSA-N 5-(3-chloro-5-ethenylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(C=C)=C1 OBISXTAFFOXIBB-UHFFFAOYSA-N 0.000 claims 1
- SSQCTUIJVJDELA-UHFFFAOYSA-N 5-(3-chloro-5-ethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound CCC1=CC(Cl)=CC(SC=2N(C(C)=C(C(N)=O)C=2C(C)C)CC=2C=CN=CC=2)=C1 SSQCTUIJVJDELA-UHFFFAOYSA-N 0.000 claims 1
- SEWHXTDZUGAFBW-UHFFFAOYSA-N 5-(3-chloro-5-phenylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC(C=1)=CC(Cl)=CC=1C1=CC=CC=C1 SEWHXTDZUGAFBW-UHFFFAOYSA-N 0.000 claims 1
- RYPVSWJTCJSRHW-UHFFFAOYSA-N 5-(3-chloro-5-propylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound CCCC1=CC(Cl)=CC(SC=2N(C(C)=C(C(N)=O)C=2C(C)C)CC=2C=CN=CC=2)=C1 RYPVSWJTCJSRHW-UHFFFAOYSA-N 0.000 claims 1
- IYODVKAEHLOXQV-UHFFFAOYSA-N 5-(3-cyanophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC=CC(C#N)=C1 IYODVKAEHLOXQV-UHFFFAOYSA-N 0.000 claims 1
- RJILOVFSTQONGB-UHFFFAOYSA-N 5-[3-chloro-5-(hydroxymethyl)phenyl]sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxamide Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(N)=O)C(C(C)C)=C1SC1=CC(Cl)=CC(CO)=C1 RJILOVFSTQONGB-UHFFFAOYSA-N 0.000 claims 1
- CDNABGYJAQBHLZ-UHFFFAOYSA-N [1-[(5-chloro-1-benzothiophen-3-yl)methyl]-5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound CC(C)C=1C(CO)=C(C)N(CC=2C3=CC(Cl)=CC=C3SC=2)C=1SC1=CC=CC(Cl)=C1 CDNABGYJAQBHLZ-UHFFFAOYSA-N 0.000 claims 1
- XMRHOXXPURONKD-UHFFFAOYSA-N [1-benzyl-5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=CC=C1 XMRHOXXPURONKD-UHFFFAOYSA-N 0.000 claims 1
- ZMOPUIZYNALBBE-UHFFFAOYSA-N [2-[4-(hydroxymethyl)-5-methyl-3-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-2-yl]sulfanylphenyl]methanol Chemical compound C=1C=CC=C(CO)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 ZMOPUIZYNALBBE-UHFFFAOYSA-N 0.000 claims 1
- NQOOBTUSKLFNLE-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)-5-(2,4,6-trichlorophenyl)sulfanylpyrrol-3-yl]methanol Chemical compound ClC=1C=C(Cl)C=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 NQOOBTUSKLFNLE-UHFFFAOYSA-N 0.000 claims 1
- SMAZWTLZKPZNJG-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)-5-(2,4,6-trimethylphenyl)sulfanylpyrrol-3-yl]methanol Chemical compound CC=1C=C(C)C=C(C)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 SMAZWTLZKPZNJG-UHFFFAOYSA-N 0.000 claims 1
- CSBLWKUHTZIFKF-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)-5-(2-pyridin-3-ylphenyl)sulfanylpyrrol-3-yl]methanol Chemical compound C=1C=CC=C(C=2C=NC=CC=2)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 CSBLWKUHTZIFKF-UHFFFAOYSA-N 0.000 claims 1
- WBGJSLFDESEQAP-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)-5-[3-(trifluoromethyl)phenyl]sulfanylpyrrol-3-yl]methanol Chemical compound C=1C=CC(C(F)(F)F)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 WBGJSLFDESEQAP-UHFFFAOYSA-N 0.000 claims 1
- LBKRVDUBJWYYKE-UHFFFAOYSA-N [2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)-5-[4-(trifluoromethoxy)phenyl]sulfanylpyrrol-3-yl]methanol Chemical compound C=1C=C(OC(F)(F)F)C=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 LBKRVDUBJWYYKE-UHFFFAOYSA-N 0.000 claims 1
- CTMIKOKQUFLLQL-UHFFFAOYSA-N [2-methyl-5-(2-phenylphenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 CTMIKOKQUFLLQL-UHFFFAOYSA-N 0.000 claims 1
- KRIXHHVXWBKTEG-UHFFFAOYSA-N [2-methyl-5-(3-methylphenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(C)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 KRIXHHVXWBKTEG-UHFFFAOYSA-N 0.000 claims 1
- XQGDTCQIVDKLPN-UHFFFAOYSA-N [2-methyl-5-(3-phenylphenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(C=2C=CC=CC=2)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 XQGDTCQIVDKLPN-UHFFFAOYSA-N 0.000 claims 1
- ZLMCCJAJWRHQQE-UHFFFAOYSA-N [2-methyl-5-(4-methylphenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C(C)C=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 ZLMCCJAJWRHQQE-UHFFFAOYSA-N 0.000 claims 1
- POAQJHJQFKZXPN-UHFFFAOYSA-N [2-methyl-5-naphthalen-2-ylsulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C2C=CC=CC2=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 POAQJHJQFKZXPN-UHFFFAOYSA-N 0.000 claims 1
- VWWVSOUEGLCMHV-UHFFFAOYSA-N [5-(2,4-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C(Cl)C=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 VWWVSOUEGLCMHV-UHFFFAOYSA-N 0.000 claims 1
- ADLDQSZXDXNLMG-UHFFFAOYSA-N [5-(2,4-dimethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C(C)C=C(C)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 ADLDQSZXDXNLMG-UHFFFAOYSA-N 0.000 claims 1
- QBCPJEHXVBRSEX-UHFFFAOYSA-N [5-(2,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 QBCPJEHXVBRSEX-UHFFFAOYSA-N 0.000 claims 1
- ZIQDPKKGAHEXQO-UHFFFAOYSA-N [5-(2,5-dimethoxyphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound COC1=CC=C(OC)C(SC=2N(C(C)=C(CO)C=2C(C)C)CC=2C=CN=CC=2)=C1 ZIQDPKKGAHEXQO-UHFFFAOYSA-N 0.000 claims 1
- IFLLMXQCNFWUMG-UHFFFAOYSA-N [5-(2,5-dimethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(C)=CC=C(C)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 IFLLMXQCNFWUMG-UHFFFAOYSA-N 0.000 claims 1
- AMXVPMAWANZAAK-UHFFFAOYSA-N [5-(2-chloro-4-fluorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C(F)C=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 AMXVPMAWANZAAK-UHFFFAOYSA-N 0.000 claims 1
- PGHSMWYFLWJAAT-UHFFFAOYSA-N [5-(2-chloro-6-methylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound CC=1C=CC=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 PGHSMWYFLWJAAT-UHFFFAOYSA-N 0.000 claims 1
- WNMCNWJAIDNXLU-UHFFFAOYSA-N [5-(2-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC=C(Cl)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 WNMCNWJAIDNXLU-UHFFFAOYSA-N 0.000 claims 1
- GCQLGDDZRYPJPN-UHFFFAOYSA-N [5-(2-fluorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC=C(F)C=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 GCQLGDDZRYPJPN-UHFFFAOYSA-N 0.000 claims 1
- GIQZRGKRLFALQY-UHFFFAOYSA-N [5-(2-methoxyphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound COC1=CC=CC=C1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 GIQZRGKRLFALQY-UHFFFAOYSA-N 0.000 claims 1
- MYKHOJDMKRUGDF-UHFFFAOYSA-N [5-(3,4-dimethoxyphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C1=C(OC)C(OC)=CC=C1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 MYKHOJDMKRUGDF-UHFFFAOYSA-N 0.000 claims 1
- HGOZMMZKQRLAJO-UHFFFAOYSA-N [5-(3,4-dimethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=C(C)C(C)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 HGOZMMZKQRLAJO-UHFFFAOYSA-N 0.000 claims 1
- ZNJRRIHFOIBLMG-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2,4-di(propan-2-yl)-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C(C)C)N1CC1=CC=NC=C1 ZNJRRIHFOIBLMG-UHFFFAOYSA-N 0.000 claims 1
- CZYNOBRIFAMWJI-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methylurea Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CNC(N)=O)=C(C)N1CC1=CC=NC=C1 CZYNOBRIFAMWJI-UHFFFAOYSA-N 0.000 claims 1
- KCZBDRIBHZAZHT-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-phenyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=NC=CC=1CN1C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C(CO)=C1C1=CC=CC=C1 KCZBDRIBHZAZHT-UHFFFAOYSA-N 0.000 claims 1
- MNZQRPJEROGNOL-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-1-[(3-methoxyphenyl)methyl]-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound COC1=CC=CC(CN2C(=C(C(C)C)C(CO)=C2C)SC=2C=C(Cl)C=CC=2)=C1 MNZQRPJEROGNOL-UHFFFAOYSA-N 0.000 claims 1
- KFOZMYPRIAPXBU-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-1-[(4-methoxyphenyl)methyl]-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound C1=CC(OC)=CC=C1CN1C(SC=2C=C(Cl)C=CC=2)=C(C(C)C)C(CO)=C1C KFOZMYPRIAPXBU-UHFFFAOYSA-N 0.000 claims 1
- YMVCEAPMPDUMJE-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-1-[[4-chloro-2-(trifluoromethyl)quinolin-6-yl]methyl]-2-methyl-4-propan-2-ylpyrrol-3-yl]methanol Chemical compound CC(C)C=1C(CO)=C(C)N(CC=2C=C3C(Cl)=CC(=NC3=CC=2)C(F)(F)F)C=1SC1=CC=CC(Cl)=C1 YMVCEAPMPDUMJE-UHFFFAOYSA-N 0.000 claims 1
- NBUHXLOUSXQREK-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-2,4-di(propan-2-yl)-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C(C)C)N1CC1=CC=NC=C1 NBUHXLOUSXQREK-UHFFFAOYSA-N 0.000 claims 1
- NOKQCBUKJRTBRY-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(1,3-thiazol-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CSC=N1 NOKQCBUKJRTBRY-UHFFFAOYSA-N 0.000 claims 1
- XDOUQOXQEAMPOZ-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(quinolin-2-ylmethyl)pyrrol-3-yl]methanol Chemical compound CC(C)C=1C(CO)=C(C)N(CC=2N=C3C=CC=CC3=CC=2)C=1SC1=CC=CC(Cl)=C1 XDOUQOXQEAMPOZ-UHFFFAOYSA-N 0.000 claims 1
- LOHNPBWEZPLJFU-UHFFFAOYSA-N [5-(3-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyrrol-3-yl]methanol Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=C(C(F)(F)F)N=C1 LOHNPBWEZPLJFU-UHFFFAOYSA-N 0.000 claims 1
- GODGHCDHDGVVCY-UHFFFAOYSA-N [5-(3-fluorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C=1C=CC(F)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 GODGHCDHDGVVCY-UHFFFAOYSA-N 0.000 claims 1
- KZMWHEJKBLWVNF-UHFFFAOYSA-N [5-(4-ethylphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C1=CC(CC)=CC=C1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 KZMWHEJKBLWVNF-UHFFFAOYSA-N 0.000 claims 1
- AGOHDWBABPUMCT-UHFFFAOYSA-N [5-(4-methoxyphenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methanol Chemical compound C1=CC(OC)=CC=C1SC1=C(C(C)C)C(CO)=C(C)N1CC1=CC=NC=C1 AGOHDWBABPUMCT-UHFFFAOYSA-N 0.000 claims 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 1
- WTKOUCTVXOOXQW-UHFFFAOYSA-N ethyl 2-[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]-2-hydroxyacetate Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(C(O)C(=O)OCC)=C(C)N1CC1=CC=NC=C1 WTKOUCTVXOOXQW-UHFFFAOYSA-N 0.000 claims 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims 1
- AJVVSYQESRHMEP-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]-2-pyridin-4-ylacetamide Chemical compound CC=1N(CC=2C=CN=CC=2)C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C=1CNC(=O)CC1=CC=NC=C1 AJVVSYQESRHMEP-UHFFFAOYSA-N 0.000 claims 1
- DIMGSFCUWSIEFO-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]-4-methylbenzenesulfonamide Chemical compound CC=1N(CC=2C=CN=CC=2)C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C=1CNS(=O)(=O)C1=CC=C(C)C=C1 DIMGSFCUWSIEFO-UHFFFAOYSA-N 0.000 claims 1
- NFZAKPIRQMORAV-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]acetamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CNC(C)=O)=C(C)N1CC1=CC=NC=C1 NFZAKPIRQMORAV-UHFFFAOYSA-N 0.000 claims 1
- VLNSMDKZVLXDIM-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]benzamide Chemical compound CC=1N(CC=2C=CN=CC=2)C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C=1CNC(=O)C1=CC=CC=C1 VLNSMDKZVLXDIM-UHFFFAOYSA-N 0.000 claims 1
- ZGTRBABHRASKLT-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]benzenesulfonamide Chemical compound CC=1N(CC=2C=CN=CC=2)C(SC=2C=C(Cl)C=C(Cl)C=2)=C(C(C)C)C=1CNS(=O)(=O)C1=CC=CC=C1 ZGTRBABHRASKLT-UHFFFAOYSA-N 0.000 claims 1
- CYSOJDVFFFWRGI-UHFFFAOYSA-N n-[[5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrol-3-yl]methyl]methanesulfonamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CNS(C)(=O)=O)=C(C)N1CC1=CC=NC=C1 CYSOJDVFFFWRGI-UHFFFAOYSA-N 0.000 claims 1
- CYTOFGPAVACHLO-UHFFFAOYSA-N n-benzyl-2-[2-(3-chlorophenyl)sulfanyl-4-(hydroxymethyl)-5-methyl-3-propan-2-ylpyrrol-1-yl]acetamide Chemical compound C=1C=CC(Cl)=CC=1SC1=C(C(C)C)C(CO)=C(C)N1CC(=O)NCC1=CC=CC=C1 CYTOFGPAVACHLO-UHFFFAOYSA-N 0.000 claims 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- CISXNMUCZSWIDW-UHFFFAOYSA-N tert-butyl 5-(3,5-dibromophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxylate Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(=O)OC(C)(C)C)C(C(C)C)=C1SC1=CC(Br)=CC(Br)=C1 CISXNMUCZSWIDW-UHFFFAOYSA-N 0.000 claims 1
- XUJMNBHXKKZDQE-UHFFFAOYSA-N tert-butyl 5-(3-bromo-5-chlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)pyrrole-3-carboxylate Chemical compound C=1C=NC=CC=1CN1C(C)=C(C(=O)OC(C)(C)C)C(C(C)C)=C1SC1=CC(Cl)=CC(Br)=C1 XUJMNBHXKKZDQE-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 11
- 102100034343 Integrase Human genes 0.000 abstract description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract description 5
- 230000029812 viral genome replication Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract description 2
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000004367 cycloalkylaryl group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 177
- 238000006243 chemical reaction Methods 0.000 description 116
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 90
- 239000000243 solution Substances 0.000 description 80
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
- 238000001819 mass spectrum Methods 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000000741 silica gel Substances 0.000 description 28
- 229910002027 silica gel Inorganic materials 0.000 description 28
- 238000003818 flash chromatography Methods 0.000 description 27
- 239000000284 extract Substances 0.000 description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 24
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 20
- 238000010828 elution Methods 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000543 intermediate Substances 0.000 description 13
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000012267 brine Substances 0.000 description 11
- 150000002430 hydrocarbons Chemical group 0.000 description 11
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000012280 lithium aluminium hydride Substances 0.000 description 9
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 8
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 239000012442 inert solvent Substances 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 7
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 5
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 5
- 208000031886 HIV Infections Diseases 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 239000012948 isocyanate Substances 0.000 description 5
- 150000002513 isocyanates Chemical class 0.000 description 5
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- 238000010561 standard procedure Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012285 osmium tetroxide Substances 0.000 description 4
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 125000004076 pyridyl group Chemical group 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 201000011531 vascular cancer Diseases 0.000 description 4
- INSIHEPGWOLTHR-UHFFFAOYSA-N 1-amino-3-methylbutan-2-one;hydrochloride Chemical compound Cl.CC(C)C(=O)CN INSIHEPGWOLTHR-UHFFFAOYSA-N 0.000 description 3
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidine Chemical compound CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 3
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 239000007818 Grignard reagent Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 125000000815 N-oxide group Chemical group 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical class N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 125000004043 oxo group Chemical group O=* 0.000 description 3
- 239000001301 oxygen Chemical group 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- 239000003880 polar aprotic solvent Substances 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 125000003107 substituted aryl group Chemical group 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- DFPYXQYWILNVAU-UHFFFAOYSA-N 1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1.C1=CC=C2N(O)N=NC2=C1 DFPYXQYWILNVAU-UHFFFAOYSA-N 0.000 description 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
- GRNOZCCBOFGDCL-UHFFFAOYSA-N 2,2,2-trichloroacetyl isocyanate Chemical compound ClC(Cl)(Cl)C(=O)N=C=O GRNOZCCBOFGDCL-UHFFFAOYSA-N 0.000 description 2
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 2
- YBGBTQXCWHOVIF-UHFFFAOYSA-N 2-amino-n-methoxy-n-methylacetamide Chemical compound CON(C)C(=O)CN YBGBTQXCWHOVIF-UHFFFAOYSA-N 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 2
- AHFINSWGYAZBOZ-UHFFFAOYSA-N 4-chloro-2-(trifluoromethyl)benzaldehyde Chemical group FC(F)(F)C1=CC(Cl)=CC=C1C=O AHFINSWGYAZBOZ-UHFFFAOYSA-N 0.000 description 2
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 241000400611 Eucalyptus deanei Species 0.000 description 2
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 2
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 150000001422 N-substituted pyrroles Chemical class 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 2
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001728 carbonyl compounds Chemical class 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000006352 cycloaddition reaction Methods 0.000 description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- KFGVRWGDTLZAAO-UHFFFAOYSA-N cyclopenta-1,3-diene dicyclohexyl(cyclopenta-1,3-dien-1-yl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.C1CCC(CC1)P(C1CCCCC1)c1ccc[cH-]1 KFGVRWGDTLZAAO-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 2
- STRNXFOUBFLVIN-UHFFFAOYSA-N diethyl but-2-ynedioate Chemical compound CCOC(=O)C#CC(=O)OCC STRNXFOUBFLVIN-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- PUSUENUSFHDMRB-UHFFFAOYSA-N ethyl 2-methyl-4-propan-2-yl-1h-pyrrole-3-carboxylate Chemical compound CCOC(=O)C1=C(C)NC=C1C(C)C PUSUENUSFHDMRB-UHFFFAOYSA-N 0.000 description 2
- KAYUYGQODIQHTK-UHFFFAOYSA-N ethyl 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-pyridin-4-ylpyrrole-3-carboxylate Chemical compound CC(C)C=1C(C(=O)OCC)=C(C)N(C=2C=CN=CC=2)C=1SC1=CC(Cl)=CC(Cl)=C1 KAYUYGQODIQHTK-UHFFFAOYSA-N 0.000 description 2
- OWGKRJVCMPQBIE-UHFFFAOYSA-N ethyl 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1h-pyrrole-3-carboxylate Chemical compound CCOC(=O)C1=C(C)NC(SC=2C=C(Cl)C=C(Cl)C=2)=C1C(C)C OWGKRJVCMPQBIE-UHFFFAOYSA-N 0.000 description 2
- YRYJBXPPLCNSCC-UHFFFAOYSA-N ethyl 5-iodo-2-methyl-4-propan-2-yl-1h-pyrrole-3-carboxylate Chemical compound CCOC(=O)C1=C(C)NC(I)=C1C(C)C YRYJBXPPLCNSCC-UHFFFAOYSA-N 0.000 description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 230000003463 hyperproliferative effect Effects 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000026045 iodination Effects 0.000 description 2
- 238000006192 iodination reaction Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- ZBDZVTOURNGNIQ-UHFFFAOYSA-M potassium;hydrogen peroxide;iodide Chemical compound [K+].[I-].OO ZBDZVTOURNGNIQ-UHFFFAOYSA-M 0.000 description 2
- 150000003138 primary alcohols Chemical class 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000002976 reverse transcriptase assay Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- 238000009097 single-agent therapy Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000005987 sulfurization reaction Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- DJCKBSARRCKOLD-UHFFFAOYSA-N tert-butyl n-(3-methyl-2-oxobutyl)carbamate Chemical compound CC(C)C(=O)CNC(=O)OC(C)(C)C DJCKBSARRCKOLD-UHFFFAOYSA-N 0.000 description 2
- XJVZHKXGDQXSNT-UHFFFAOYSA-N tert-butyl n-[2-[methoxy(methyl)amino]-2-oxoethyl]carbamate Chemical compound CON(C)C(=O)CNC(=O)OC(C)(C)C XJVZHKXGDQXSNT-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 206010055031 vascular neoplasm Diseases 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- BLFRMOOGAICNSZ-UHFFFAOYSA-N (2,4,6-trimethoxyphenyl)methanamine;hydrochloride Chemical compound Cl.COC1=CC(OC)=C(CN)C(OC)=C1 BLFRMOOGAICNSZ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- JMQANWHMOHXBEA-UHFFFAOYSA-N 1,3-dichloro-5-[(3,5-dichlorophenyl)disulfanyl]benzene Chemical compound ClC1=CC(Cl)=CC(SSC=2C=C(Cl)C=C(Cl)C=2)=C1 JMQANWHMOHXBEA-UHFFFAOYSA-N 0.000 description 1
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 description 1
- WTAPZWXVSZMMDG-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WTAPZWXVSZMMDG-UHFFFAOYSA-N 0.000 description 1
- UNYDWXGETNKFSJ-UHFFFAOYSA-N 1-amino-3-methylbutan-2-one Chemical compound CC(C)C(=O)CN UNYDWXGETNKFSJ-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- JLIDVCMBCGBIEY-UHFFFAOYSA-N 1-penten-3-one Chemical group CCC(=O)C=C JLIDVCMBCGBIEY-UHFFFAOYSA-N 0.000 description 1
- AKWIAIDKXNKXDI-UHFFFAOYSA-N 1h-pyrrole-3-carboxamide Chemical compound NC(=O)C=1C=CNC=1 AKWIAIDKXNKXDI-UHFFFAOYSA-N 0.000 description 1
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- 125000003070 2-(2-chlorophenyl)ethyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000002856 2-fluorophenylethyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000940 2-methoxyphenyl ethyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004362 3,4,5-trichlorophenyl group Chemical group [H]C1=C(Cl)C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- VAJUUDUWDNCECT-UHFFFAOYSA-N 4-(bromomethyl)pyridine;hydron;bromide Chemical compound Br.BrCC1=CC=NC=C1 VAJUUDUWDNCECT-UHFFFAOYSA-N 0.000 description 1
- WZIYCIBURCPKAR-UHFFFAOYSA-N 4-(chloromethyl)pyridine Chemical compound ClCC1=CC=NC=C1 WZIYCIBURCPKAR-UHFFFAOYSA-N 0.000 description 1
- VTPMLHXUTSIENQ-UHFFFAOYSA-N 4-[[4-(chloromethyl)-2-(3,5-dichlorophenyl)sulfanyl-5-methyl-3-propan-2-ylpyrrol-1-yl]methyl]pyridine Chemical compound C=1C(Cl)=CC(Cl)=CC=1SC1=C(C(C)C)C(CCl)=C(C)N1CC1=CC=NC=C1 VTPMLHXUTSIENQ-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical class C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 description 1
- TUMGGBZBYMSXIG-UHFFFAOYSA-N 5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-pyridin-4-ylpyrrole-3-carbaldehyde Chemical compound CC(C)C=1C(C=O)=C(C)N(C=2C=CN=CC=2)C=1SC1=CC(Cl)=CC(Cl)=C1 TUMGGBZBYMSXIG-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- RAWQIUXGVSKRSY-UHFFFAOYSA-N C(C)(C)C1=C(N(C=C1)CC1=CC=NC=C1)C Chemical compound C(C)(C)C1=C(N(C=C1)CC1=CC=NC=C1)C RAWQIUXGVSKRSY-UHFFFAOYSA-N 0.000 description 1
- PSXLCTPHDAEPLK-UHFFFAOYSA-N CC(C)[Mg] Chemical compound CC(C)[Mg] PSXLCTPHDAEPLK-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- XPOQHMRABVBWPR-UHFFFAOYSA-N Efavirenz Natural products O1C(=O)NC2=CC=C(Cl)C=C2C1(C(F)(F)F)C#CC1CC1 XPOQHMRABVBWPR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical group Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010038997 Retroviral infections Diseases 0.000 description 1
- 229910005948 SO2Cl Inorganic materials 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- KYHJYKMWQIHYIY-UHFFFAOYSA-N [5-(3,5-dichlorophenyl)sulfanyl-2-methyl-4-propan-2-yl-1-pyridin-4-ylpyrrol-3-yl]methanol Chemical compound CC(C)C=1C(CO)=C(C)N(C=2C=CN=CC=2)C=1SC1=CC(Cl)=CC(Cl)=C1 KYHJYKMWQIHYIY-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 238000002832 anti-viral assay Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 1
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical group CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125890 compound Ia Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 1
- 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 description 1
- 125000005169 cycloalkylcarbonylamino group Chemical group 0.000 description 1
- 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 description 1
- 125000005149 cycloalkylsulfinyl group Chemical group 0.000 description 1
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000006298 dechlorination reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 1
- 125000005202 dialkylaminocarbonyloxy group Chemical group 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000005050 dihydrooxazolyl group Chemical group O1C(NC=C1)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- XPOQHMRABVBWPR-ZDUSSCGKSA-N efavirenz Chemical compound C([C@]1(C2=CC(Cl)=CC=C2NC(=O)O1)C(F)(F)F)#CC1CC1 XPOQHMRABVBWPR-ZDUSSCGKSA-N 0.000 description 1
- 229960003804 efavirenz Drugs 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 description 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 description 1
- 125000004468 heterocyclylthio group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- NIZHERJWXFHGGU-UHFFFAOYSA-N isocyanato(trimethyl)silane Chemical compound C[Si](C)(C)N=C=O NIZHERJWXFHGGU-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001620 monocyclic carbocycle group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- VMESOKCXSYNAKD-UHFFFAOYSA-N n,n-dimethylhydroxylamine Chemical compound CN(C)O VMESOKCXSYNAKD-UHFFFAOYSA-N 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- DZOOXMGZVWHNAS-UHFFFAOYSA-N pent-3-yn-2-one Chemical compound CC#CC(C)=O DZOOXMGZVWHNAS-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003140 primary amides Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
- PCZOZSATUTWXIC-UHFFFAOYSA-N tetraethylazanium;cyanide Chemical compound N#[C-].CC[N+](CC)(CC)CC PCZOZSATUTWXIC-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- YLGRTLMDMVAFNI-UHFFFAOYSA-N tributyl(prop-2-enyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)CC=C YLGRTLMDMVAFNI-UHFFFAOYSA-N 0.000 description 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 239000004066 vascular targeting agent Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0016453.3A GB0016453D0 (en) | 2000-07-04 | 2000-07-04 | Pyrrole derivatives |
| PCT/EP2001/004832 WO2002002524A1 (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502674A true JP2004502674A (ja) | 2004-01-29 |
| JP2004502674A5 JP2004502674A5 (enExample) | 2005-02-24 |
Family
ID=9895031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002507781A Pending JP2004502674A (ja) | 2000-07-04 | 2001-04-30 | エイズを治療するためのピロール誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6737429B2 (enExample) |
| EP (1) | EP1301481A1 (enExample) |
| JP (1) | JP2004502674A (enExample) |
| KR (1) | KR100549884B1 (enExample) |
| CN (1) | CN1440385A (enExample) |
| AR (1) | AR028602A1 (enExample) |
| AU (2) | AU2001263874B2 (enExample) |
| BR (1) | BR0112241A (enExample) |
| CA (1) | CA2412270A1 (enExample) |
| EC (1) | ECSP014109A (enExample) |
| GB (1) | GB0016453D0 (enExample) |
| GT (1) | GT200100111A (enExample) |
| MX (1) | MXPA02012409A (enExample) |
| PA (1) | PA8516201A1 (enExample) |
| PE (1) | PE20020269A1 (enExample) |
| UY (1) | UY26720A1 (enExample) |
| WO (1) | WO2002002524A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1405849A1 (en) * | 2002-10-04 | 2004-04-07 | Corning Incorporated | Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom |
| CA2551602C (en) * | 2003-12-26 | 2013-03-26 | Masatoshi Hagiwara | Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| US8048909B2 (en) | 2004-09-30 | 2011-11-01 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
| TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
| WO2006072833A1 (en) * | 2005-01-06 | 2006-07-13 | Pfizer Limited | Imidazole derivatives as enzyme reverse transcriptase modulators |
| US7977488B2 (en) | 2005-08-30 | 2011-07-12 | Takeda Pharmaceutical Company Limited | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
| JP2010505834A (ja) * | 2006-10-06 | 2010-02-25 | メルク エンド カムパニー インコーポレーテッド | 非ヌクレオシド系逆転写酵素阻害剤 |
| WO2008058287A1 (en) * | 2006-11-10 | 2008-05-15 | Syndax Pharmaceuticals, Inc. | COMBINATION OF ERα+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER |
| US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| WO2009015180A2 (en) * | 2007-07-23 | 2009-01-29 | Syndax Pharmaceuticals, Inc. | Novel compounds and methods of using them |
| SG185313A1 (en) * | 2007-10-16 | 2012-11-29 | Nikon Corp | Illumination optical system, exposure apparatus, and device manufacturing method |
| US20090131367A1 (en) * | 2007-11-19 | 2009-05-21 | The Regents Of The University Of Colorado | Combinations of HDAC Inhibitors and Proteasome Inhibitors |
| KR101629181B1 (ko) | 2008-08-27 | 2016-06-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤 화합물 |
| GB0823001D0 (en) * | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Thiophene,furan and pyrrole derivatives with plant growth regulating properties |
| CN101775011B (zh) * | 2009-01-13 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用 |
| CN114727987A (zh) * | 2019-11-19 | 2022-07-08 | 纽约血库公司 | 具有hiv治疗活性的经取代杂环化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3644631A (en) * | 1969-05-13 | 1972-02-22 | Endo Lab | Therapeutic methods utilizing aryl pyrrol-3-yl ketones |
| US4282242A (en) * | 1980-03-07 | 1981-08-04 | Pfizer Inc. | Antidiabetic pyrrolecarboxylic acids |
| US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
| BR9307664A (pt) * | 1992-12-17 | 1999-06-29 | Pfizer | Pirazóis substituídos como antagonistas |
| CA2192208C (en) * | 1994-06-06 | 2002-09-10 | Pfizer Limited | Substituted pyrazoles |
| TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
| US6417202B1 (en) * | 1996-07-11 | 2002-07-09 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin-and TNF antagonists |
| DE19963174A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Pyrrol-Mannichbasen |
-
2000
- 2000-07-04 GB GBGB0016453.3A patent/GB0016453D0/en not_active Ceased
-
2001
- 2001-04-30 BR BR0112241-0A patent/BR0112241A/pt not_active IP Right Cessation
- 2001-04-30 KR KR1020037000138A patent/KR100549884B1/ko not_active Expired - Fee Related
- 2001-04-30 EP EP01938137A patent/EP1301481A1/en not_active Withdrawn
- 2001-04-30 AU AU2001263874A patent/AU2001263874B2/en not_active Ceased
- 2001-04-30 CN CN01812290A patent/CN1440385A/zh active Pending
- 2001-04-30 WO PCT/EP2001/004832 patent/WO2002002524A1/en not_active Ceased
- 2001-04-30 CA CA002412270A patent/CA2412270A1/en not_active Abandoned
- 2001-04-30 JP JP2002507781A patent/JP2004502674A/ja active Pending
- 2001-04-30 MX MXPA02012409A patent/MXPA02012409A/es active IP Right Grant
- 2001-04-30 AU AU6387401A patent/AU6387401A/xx active Pending
- 2001-05-04 PA PA20018516201A patent/PA8516201A1/es unknown
- 2001-05-18 UY UY26720A patent/UY26720A1/es not_active Application Discontinuation
- 2001-05-22 AR ARP010102414A patent/AR028602A1/es not_active Application Discontinuation
- 2001-05-25 PE PE2001000487A patent/PE20020269A1/es not_active Application Discontinuation
- 2001-06-12 GT GT200100111A patent/GT200100111A/es unknown
- 2001-06-13 US US09/880,534 patent/US6737429B2/en not_active Expired - Fee Related
- 2001-07-04 EC EC2001004109A patent/ECSP014109A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2412270A1 (en) | 2002-01-10 |
| GT200100111A (es) | 2002-03-18 |
| UY26720A1 (es) | 2001-11-30 |
| WO2002002524A1 (en) | 2002-01-10 |
| AU6387401A (en) | 2002-01-14 |
| EP1301481A1 (en) | 2003-04-16 |
| GB0016453D0 (en) | 2000-08-23 |
| KR100549884B1 (ko) | 2006-02-06 |
| MXPA02012409A (es) | 2003-04-25 |
| US20020032221A1 (en) | 2002-03-14 |
| PE20020269A1 (es) | 2002-04-08 |
| US6737429B2 (en) | 2004-05-18 |
| KR20030014321A (ko) | 2003-02-15 |
| CN1440385A (zh) | 2003-09-03 |
| BR0112241A (pt) | 2003-06-24 |
| ECSP014109A (es) | 2002-02-25 |
| PA8516201A1 (es) | 2002-07-30 |
| AU2001263874B2 (en) | 2006-10-19 |
| AR028602A1 (es) | 2003-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100633844B1 (ko) | 2-시아노-4-플루오로피롤리딘 유도체 또는 그의 염 | |
| AU2001234128B2 (en) | Novel imidazoline compounds | |
| KR100669839B1 (ko) | 소염제로서의 방향족 헤테로사이클릭 화합물 및 이의 제조방법 | |
| JP2004502674A (ja) | エイズを治療するためのピロール誘導体 | |
| TWI399380B (zh) | 抗病毒化合物 | |
| CA2932010C (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| KR100245138B1 (ko) | 퀴녹살린,이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| US20040147506A1 (en) | Benzimidazolone derivatives | |
| JP2013545740A (ja) | バニロイド受容体リガンドとしての置換された複素芳香族カルボキサミド誘導体および尿素誘導体 | |
| WO2006068163A1 (ja) | 二環性ピロール誘導体 | |
| JP2005511608A (ja) | アミノピリミジン類及び−ピリジン類 | |
| EP1401826B1 (en) | Pyrazole derivatives as hiv reverse transcriptase inhibitors | |
| TW200306834A (en) | Aminopyrimidine compound and pharmaceutical use thereof | |
| AU2001263874A1 (en) | Pyrrole derivatives for treating aids | |
| AU2002325221A1 (en) | Pyrazole Derivatives as HIV Reverse Transcriptase Inhibitors | |
| WO2005021550A1 (ja) | 二環性ピラゾール誘導体 | |
| US6369057B1 (en) | Quinoxalines, processes for their preparation and their use | |
| JPH09509925A (ja) | インドールの新規な四置換誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての用途及びそれらを含有する製薬組成物 | |
| JPH07196511A (ja) | キノキサリンおよびヌクレオシドを含有する複合製剤 | |
| HUT52038A (en) | Process for producing alpha-cyano-beta-oxo-propion-amides | |
| SK114094A3 (en) | Peptides, method of their producing, their using and pharmaceutical preparation on their base | |
| JP2004514672A (ja) | ウイルス疾患の処置のためのイミダゾロン誘導体 | |
| SK7602003A3 (en) | Novel compounds for use as HIV protease inhibitors | |
| JP2887522B2 (ja) | 新規なトリアゾール誘導体およびその塩 | |
| JP2003048875A (ja) | 1,2−エタンジアミン誘導体の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060214 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060512 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060526 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060811 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080108 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080610 |